Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Squamous Cell Carcinoma of Head and Neck 4 Neoplasms 3 Head and Neck Neoplasms 2 Endometrial Neoplasms 2 Stomach Neoplasms 1 Rectal Neoplasms 1 Ovarian Carcinosarcoma 1 Oropharyngeal Neoplasms 1 Neoplasm Metastasis 1 Mouth Neoplasms 1 Laryngeal Diseases 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Squamous Cell 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1

Interventions

Oxaliplatin 9 Leucovorin 8 Fluorouracil 8 Bevacizumab 6 Cetuximab 5 Specimen Handling 4 fludarabine 3 Pemetrexed 3 Nivolumab 3 Magnetic Resonance Spectroscopy 3 Cyclophosphamide 3 pembrolizumab 2 encorafenib 2 dehydroftorafur 2 aldesleukin 2 Laparoscopy 2 Irinotecan 2 Immunoglobulin G 2 Gemcitabine 2 Folfox protocol 2 Disulfides 2 Conversion to Open Surgery 2 Cisplatin 2 Celecoxib 2 Carboplatin 2 ulixertinib 1 trastuzumab biosimilar HLX02 1 trametinib 1 temsirolimus 1 sapanisertib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Colonic Neoplasms × dostarlimab × 30 days × Clear all

NCT06567782 2026-05-22

AZUR-4

GlaxoSmithKline

Phase 2 Recruiting

Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡